Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Anti-inflammatory Effects of Glycopyrronium Added to Indacaterol/Mometasone on the Allergen-induced Late Asthmatic Response

NCT04259164 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT04259164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04259164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Anti-inflammatory Effects of Glycopyrronium Added to Indacaterol/Mometasone on the Allergen-induced Late Asthmatic Response
Lead sponsor
University Medical Center Groningen
Phase
Phase 3
Overall status
Completed
Start date
September 10, 2020
Completion date
December 29, 2022
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma, asthma